Long Term Outcome of Patients Receiving Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Haematologic Malignancies

被引：0
|
作者：
Tang, Si Ying [1 ,2 ]
Linn, Yeh Ching [3 ]
Tai, Bee Choo [4 ]
Poon, Michelle L. M. [1 ]
Tan, Lip Kun [1 ]
Tan, Belinda [1 ]
Lim, Yelly [1 ]
Soh, Teck Guan [1 ]
Ramos, Davanaliz Gonzales [1 ]
Hwang, William Y. K. [3 ]
Koh, Liang Piu [1 ,2 ]
机构：
[1] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Dept Med, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore
[4] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P182
引用
收藏
页码：279 / 279
页数：1
相关论文
共 50 条
  • [1] Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
    Sorror, Mohamed L.
    Sandmaier, Brenda M.
    Storer, Barry E.
    Franke, Georg N.
    Laport, Ginna G.
    Chauncey, Thomas R.
    Agura, Edward
    Maziarz, Richard T.
    Langston, Amelia
    Hari, Parameswaran
    Pulsipher, Michael A.
    Bethge, Wolfgang
    Sahebi, Firoozeh
    Bruno, Benedetto
    Maris, Michael B.
    Yeager, Andrew
    Petersen, Finn Bo
    Vindelov, Lars
    McSweeney, Peter A.
    Huebel, Kai
    Mielcarek, Marco
    Georges, George E.
    Niederwieser, Dietger
    Blume, Karl G.
    Maloney, David G.
    Storb, Rainer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (17): : 1874 - 1883
  • [2] Allogeneic hematopoietic cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.
    Gürman, G
    Üstün, C
    Arslan, Ö
    Beksaç, M
    Konuk, N
    Arat, M
    Çelebi, H
    Özcan, M
    Ilhan, O
    Demirer, T
    Akan, H
    Uysal, A
    Koç, H
    BONE MARROW TRANSPLANTATION, 1999, 23 : S22 - S22
  • [3] Allogeneic hematopoietic stem cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.
    Gürman, G
    Üstün, C
    Arslan, O
    Beksaç, M
    Konuk, N
    Arat, M
    Celebi, H
    Özcan, M
    Ilhan, O
    Demirer, T
    Akan, H
    Uysal, A
    Koc, H
    BLOOD, 1998, 92 (10) : 350B - 351B
  • [4] Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
    Vaughn, Jennifer
    Sorror, Mohamed L.
    Chauncey, Thomas
    Pulsipher, Michael A.
    Maziarz, Richard T.
    Maris, Michael B.
    Hari, Parameswaran N.
    Laport, Ginna G.
    Franke, Georg-Nikolaus
    Agura, Edward
    Langston, Amelia
    Rezvani, Andrew
    Stor, Rainer E.
    Sandmaier, Brenda M.
    Maloney, David G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S88 - S89
  • [5] Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
    Baron, F
    Baker, JE
    Storb, R
    Gooley, TA
    Sandmaier, BM
    Maris, MB
    Maloney, DG
    Heimfeld, S
    Oparin, D
    Zellmer, E
    Radich, JP
    Grumet, FC
    Blume, KG
    Chauncey, TR
    Little, MT
    BLOOD, 2004, 104 (08) : 2254 - 2262
  • [6] Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies
    Gürman, G
    Arat, M
    Ilhan, O
    Konuk, N
    Beksaç, M
    Çelebi, H
    Özcan, M
    Arslan, Ö
    Üstün, C
    Akan, H
    Uysal, A
    Koç, H
    CYTOTHERAPY, 2001, 3 (04) : 253 - 260
  • [7] Long-term outcome of patients with severe aplastic anemia receiving allogeneic hematopoietic cell transplantation using nonmyeloablative conditioning with fludarabine and low dose total-body irradiation
    Qi, L. Cheryl Xiu
    Ching, L. Yeh
    Mei, P. Michelle Li
    Kun, T. Lip
    Khee, H. William Ying
    Tee, G. Yeow
    Chye, T. Patrick Huat
    Piu, K. Liang
    BONE MARROW TRANSPLANTATION, 2017, 52 : S416 - S416
  • [8] Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders
    Baron, F
    Storb, R
    MOLECULAR THERAPY, 2006, 13 (01) : 26 - 41
  • [9] Nonmyeloablative allogeneic hematopoietic cell transplantation
    Storb, Rainer
    Sandmaier, Brenda M.
    HAEMATOLOGICA, 2016, 101 (05) : 521 - 530
  • [10] Long-Term Outcomes of Patients with Persistent Indolent B Cell Malignancies Undergoing Nonmyeloablative Allogeneic Transplantation
    Cassaday, Ryan D.
    Storer, Barry E.
    Sorror, Mohamed L.
    Sandmaier, Brenda M.
    Guthrie, Katherine A.
    Maloney, David G.
    Rajendran, Joseph G.
    Pagel, John M.
    Flowers, Mary E.
    Green, Damian J.
    Rezvani, Andrew R.
    Storb, Rainer F.
    Press, Oliver W.
    Gopal, Ajay K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : 281 - 287
12345